← The record

Macrogol 3350

Recommended GastroenterologyRestrictedLater-line line

chronic constipation or faecal impaction not adequately controlled with first line interventions such as bulk-forming agents; patients with malignant neoplasia, paraplegic and quadriplegic patients and others with severe neurogenic impairment of bowel function

5
Submissions
1 resub
2005–07
On the record
ICER range
Not modelled
Cost basis

Decisions on record

4 decisions
  • Meeting Mar 2010 Recommended Constipation no PSD
  • Meeting Nov 2008 Recommended Laxative no PSD
  • Meeting Nov 2007 Recommended Constipation
  • Meeting Mar 2007 Recommended Laxative

Access path

5 submissions · public record
  1. Nov 2005
    Not recommended

    inadequate clinical evidence (single-arm, open-label studies with small sample size and short duration; selection and…

  2. Nov 2005
    Not recommended

    inadequate clinical evidence (single-arm, open-label studies only), potential for inappropriate use if listed as…

  3. ↻ resubmitted
    Mar 2007
    Recommended · restricted

    Comparator changed: conventional therapy (repeated enemas and suppositories, lavage…

  4. Mar 2007
    Recommended · restricted

    Comparator changed: conventional therapy (repeated enemas and suppositories, lavage…

  5. Nov 2007
    Recommended · restricted
  6. PBS listing · Restricted
RecommendedDeferredNot recommended

Cost-effectiveness

No economic evaluation generated by the sponsor was presented. Five published pharmacoeconomic studies were cited but no ICER values are stated in the document.

The PBAC considered that the evidence presented in the submission to be poor and unconvincing and acknowledged the difficulties associated with collecting data in this patient group. PBAC · 2007
ICER uncertainEconomic model disputedNo head-to-head trialIndirect comparison

Decision context

Populationpatients with chronic constipation or faecal impaction not adequately controlled with first line interventions such as bulk-forming agents; patients with malignant neoplasia, paraplegic and quadriplegic patients and others with severe neurogenic impairment of bowel function

Submission history

5 entries
DecidedOutcomeComparatorICEREvidence
Nov 2007 Recommended · restricted RCT · QoL
Mar 2007 Recommended · restricted rectal interventions such as suppositories and enemas RCT, non-comparative studies, before-and-after study · null
Mar 2007 Recommended · restricted rectal interventions (suppositories and enemas) RCT
Nov 2005 Not recommended conventional therapy (hospital admission with repeated enemas and suppositories, lavage solutions or manual disimpaction Single-arm | Registry
Nov 2005 Not recommended conventional therapy (repeated enemas and suppositories, lavage solutions, manual disimpaction, and hospital admission) Single-arm

Similar precedents

By decision profile

Regulatory · TGA

Label narrower than PBS population — PBAC restricts to chronic constipation/faecal impaction inadequately controlled by first-line agents, plus specific neurological conditions.